US Clinical Chemistry and Immunodiagnostic Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies
NEW YORK, Aug. 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
US Clinical Chemistry and Immunodiagnostic Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies
http://www.reportlinker.com/p01593918/US-Clinical-Chemistry-and-Immunodiagnostic-Market-2013-Sales-Forecasts-Supplier-Shares-Competitive-Strategies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
This comprehensive report contains 600 pages and 120 tables. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.
The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.
The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.
Tests Analyzed in the Report Include:
Routine Clinical Chemistry
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.
Endocrine Function
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.
Immunoproteins
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.
Sales and Market Share Analysis
Sales and market share estimates for leading suppliers
of clinical chemistry and immunodiagnostic products by individual product.
Competitive Assessments
Strategic assessments of major suppliers and
emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.
Market Segmentation Analysis
- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth, and key suppliers.
- Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by market segment:
- Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
Current and Emerging Products
- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.
- Review of current instrumentation technologies, and a feature comparison of high-, medium-, and low-volume/POC analyzers.
Technology Review
- Assessment of current and emerging technologies, and their potential market applications.
- Comprehensive lists of companies developing or marketing new technologies and products by test.
Strategic Recommendations
- New product development opportunities
with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Contains 600 pages and 120 tables
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin, Total
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cardio CRP
12. Cholesterol
13. Cholinesterase
14. CRP
15. Creatinine
16. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
17. Ferritin
18. Fructosamine
19. Gamma-Glutamyl Transpeptidase (GGT)
20. Glucose
21. High Density Lipoprotein (HDL)
22. Homocysteine
23. Iron
24. Lactate Dehydrogenase (LDH)
25. Magnesium
26. Phosphorus
27. Protein
28. Triglycerides
29. Uric Acid
30. Troponin
B. Therapeutic Drug Monitoring (TDM)
1. Overview
2. Carbamazepine
3. Cyclosporin
4. Digoxin
5. Everolimus
6. Gentamicin
7. Lamotrigine/Lamictal
8. Levetiracetam
9. Lidocaine
10. Lithium
11. NAPA/Procainamide
12. Phenytoin
13. Quinidine
14. Sirolimus
15. Tacrolimus
16. Theophylline
17. Topirimate
18. Valproic Acid
C. Endocrine Function Tests
1. Cortisol
2. Estradiol
3. Follicle-Stimulating Hormone (FSH)
4. Gastrin
5. Growth Hormone/IGF-1
6. Human Chorionic Gonadotropin (HCG)
7. LH
8. Progesterone
9. PTH/IO PTH
10. Prolactin
11. T3
12. T3 Free
13. T3 Uptake
14. T4 (Thyroxine)
15. T4 Free
16. TBG
17. Testosterone
18. Thyroglobulin Ab
19. TPO Ab
20. TSH
D. Tumor Markers And Special Chemistry Tests
1. AFP
2. CA 15-3
3. CA 19-9
4. CA 27-29
5. Carcinoembrionic Antigen (CEA)
6. Folate/Folic Acid
7. HCG
8. 25-Hydroxy Vitamin D2 and D3
9. Occult Blood
10. Prostate-Specific Antigen (PSA)
11. Thyroglobulin
12. Vitamin B-12
E. Immunoprotein Tests
1. Complement
a. C3
b. C4
2. Free Light Chains
3. Immunofixation
4. Immunoglobulins (IgA, IgE, IgG, IgM)
5. Haptoglobin
6. Prealbumin
7. Protein Electrophoresis
F. Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
G. Instrumentation Review: Operating characteristics
and features of high-, medium-, and low-volume/POC analyzers
H. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
VI. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers'
Instrument and Reagent Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XIII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. Competitive Assessments
- Abbott Laboratories
- AdnaGen
- Agilent Technologies
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio/Innogenetics
- Instrumentation Laboratory
- Kyowa Medex
- Matritech/Alere
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE
List of Tables
Major Companies Developing or Marketing
Albumin Tests
Major Companies Developing or Marketing
Alkaline Phosphatase Tests
Major Companies Developing or Marketing
ALT/SGPT Tests
Major Companies Developing or Marketing
Amylase Tests
Major Companies Developing or Marketing
AST/SGOT Tests
Major Companies Developing or Marketing
Bilirubin Tests
Major Companies Developing or Marketing
Blood Gas Analyzers
Major Companies Developing or Marketing
BUN Tests
Major Companies Developing or Marketing
Calcium Tests
Major Companies Developing or Marketing
Cholesterol Tests
Major Companies Developing or Marketing
Creatinine Tests
Major Companies Developing or Marketing
Electrolyte Tests
Major Companies Developing or Marketing
GGT Tests
Major Companies Developing or Marketing
Glucose Tests
Major Companies Developing or Marketing
HDL Tests
Major Companies Developing or Marketing
Iron Tests
Major Companies Developing or Marketing
LDH Tests
Major Companies Developing or Marketing
Magnesium Tests
Major Companies Developing or Marketing
Phosphorus Tests
Major Companies Developing or Marketing
Protein Tests
Major Companies Developing or Marketing
Triglycerides Tests
Major Companies Developing or Marketing
Uric Acid Tests
Major Companies Developing or Marketing
TDM Tests
Major Companies Developing or Marketing
Digoxin Tests
Major Companies Developing or Marketing
Lithium Tests
Major Companies Developing or Marketing
Phenytoin/Dilantin Tests
Major Companies Developing or Marketing
Theophylline Tests
Major Companies Developing or Marketing
Valproic Acid Tests
Major Companies Developing or Marketing
FSH Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
LH Tests
Major Companies Developing or Marketing
Prolactin Tests
Major Companies Developing or Marketing
T3 Tests
Major Companies Developing or Marketing
T4 Tests
Major Companies Developing or Marketing
TSH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
Prostatic Acid Phosphatase TestsMajor Companies Developing or Marketing
Prolactin Tests
Major Companies Developing or Marketing
T3 Tests
Major Companies Developing or Marketing
T4 Tests
Major Companies Developing or Marketing
TSH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
Prostatic Acid Phosphatase Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Vitamin B-12/Folate Tests
Major Companies Developing or Marketing
CRP Tests
Major Companies Developing or Marketing
Drugs of Abuse Tests
Major Companies Developing or Marketing
Biosensors for Immunological Testing
Executive Summary Table: U.S.A., Clinical
Chemistry and Immunoassay Test Volume
and Diagnostics Sales Forecast By Test Category
U.S.A., Laboratories Performing Chemistry
and Immunoassay Testing By Market Segment
U.S.A., Hospital Laboratories Performing
Chemistry and Immunoassay Tests By Bed Size
U.S.A., Commercial/Private Laboratories
Performing Chemistry and Immunoassay Tests
By Annual Test Volume
U.S.A., Total Chemistry and Immunoassay
Specimen Volume Forecast
U.S.A., All Market Segments, Specimen Volume
Forecast By Test Category
U.S.A., Total Clinical Chemistry and Immunoassay
Test Volume Forecast By Test Category
U.S.A., Routine Chemistry Test Volume
Forecast By Market Segment
U.S.A., TDM Test Volume Forecast
By Market Segment
U.S.A., Endocrine Function Test Volume
Forecast By Market Segment
U.S.A., Drugs of Abuse Test Volume
Forecast By Market Segment
U.S.A., Tumor Markers and Special Chemistry
Test Volume Forecast By Market Segment
U.S.A., Immunoprotein Test Volume
Forecast By Market Segment
U.S.A., All Market Segments, Profiles,
Panels and Individual Tests Forecast
U.S.A., Hospital Laboratories, Profiles,
Panels and Individual Tests Forecast
U.S.A., Commercial/Private Laboratories,
Profiles, Panels and Individual Tests Forecast
U.S.A., Physician Offices/Group Practices,
Profiles, Panels and Individual Tests Forecast
U.S.A., All Market Segments, Routine
Chemistry Test Volume Forecast
by Assay
U.S.A., Hospital Laboratories, Routine
Chemistry Test Volume Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Routine Chemistry Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Routine Chemistry Test Volume Forecast
by Assay
U.S.A., All Market Segments, TDM
Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, TDM
Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices,
TDM Test Volume Forecast by Assay
U.S.A., All Market Segments, Endocrine
Function Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Endocrine
Function Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Endocrine Function Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Endocrine Function Test Volume Forecast
by Assay
U.S.A., All Market Segments, Drugs
of Abuse Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Drugs
of Abuse Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Drugs of Abuse Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Drugs of Abuse Test Volume Forecast
by Assay
U.S.A., All Market Segments, Tumor Markers
and Special Chemistry Test Volume Forecast
by Assay
U.S.A., Hospital Laboratories, Tumor Markers
and Special Chemistry Test Volume Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Tumor Markers and Special Chemistry Test
Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices,
Tumor Markers and Special Chemistry Test
Volume Forecast by Assay
U.S.A., All Market Segments,
Immunoprotein Test Volume Forecast
by Assay
U.S.A., Hospital Laboratories,
Immunoprotein Test Volume Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Immunoprotein Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Immunoprotein Test Volume Forecast
by Assay
U.S.A., Total Clinical Chemistry and Immunoassay
Reagent Market Forecast By Test Category
U.S.A., Clinical Chemistry and Immunoassay
Calibrator and Control Market Forecast
By Test Category
U.S.A., Routine Chemistry Reagent Market
Forecast By Market Segment
U.S.A., TDM Reagent Market Forecast
By Market Segment
U.S.A., Drugs of Abuse Reagent Market
Forecast By Market Segment
U.S.A., Tumor Markers and Special Chemistry
Reagent Market Forecast By Market Segment
U.S.A., Endocrine Function Reagent Market
Forecast By Market Segment
U.S.A., All Market Segments, Routine
Chemistry Reagent Market Forecast
by Assay
U.S.A., Hospital Laboratories, Routine
Chemistry Reagent Market Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Routine Chemistry Reagent Market Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Routine Chemistry Reagent Market Forecast
by Assay
U.S.A., All Market Segments, TDM
Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, TDM
Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
U.S.A., Physician Office/Group Practices,
TDM Reagent Market Forecast by Assay
U.S.A., All Market Segments, Drugs of
Abuse Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Drugs of
Abuse Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Drugs of Abuse Reagent Market Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Drugs of Abuse Reagent Market Forecast
by Assay
U.S.A., All Market Segments, Endocrine
Function Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Endocrine
Function Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Endocrine Function Reagent Market Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Endocrine Function Reagent Market Forecast
by Assay
U.S.A., All Market Segments, Tumor Markers
and Special Chemistry Reagent Market Forecast
by Assay
U.S.A., Hospital Laboratories, Tumor Markers
and Special Chemistry Reagent Market Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Tumor Markers and Special Chemistry Reagent
Market Forecast by Assay
U.S.A., Physician Offices/Group Practices,
Tumor Markers and Special Chemistry Reagent
Market Forecast by Assay
U.S.A., All Market Segments,
Immunoprotein Reagent Market Forecast
U.S.A., Hospital Laboratories,Immunoprotein
Reagent Market Forecast Immunoprotein
U.S.A., Commercial/Private Laboratories,
Immunoprotein Reagent Market Forecast
U.S.A., Physician Offices/Group Practices,
Immunoprotein Reagent Market Forecast
by Assay
U.S.A., Major Suppliers of Clinical Chemistry
Reagents, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Clinical Chemistry
Analyzers, Estimated Instrument Sales
and Market Shares
U.S.A., Major Suppliers of Clinical Chemistry
Diagnostics Products, Estimated Sales
and Market Shares
U.S.A., Major Suppliers of Immunoassay
Reagents, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Immunoassay
Analyzers, Estimated Instrument Sales
and Market Shares
U.S.A., Major Suppliers of Immunoassay
Diagnostics Products, Estimated Sales
And Market Shares
U.S.A., Clinical Chemistry and Immunoassay
Instrument Market Forecast By Analyzer Type
To order this report:
In_Vitro_Diagnostic Industry: US Clinical Chemistry and Immunodiagnostic Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article